Related Experiment Videos
Ventricular arrhythmias. Clinical recognition and management
Cardiology Clinics
|May 1, 1984
Summary
Identifying high-risk patients allows for risk factor elimination to prevent sudden cardiac death. Antiarrhythmic agents are recommended for chronic ventricular ectopy, especially in left ventricular dysfunction, with new agents forthcoming.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Sudden cardiac death (SCD) is a significant concern.
- Identifying patients at high risk for SCD is crucial for prevention strategies.
Purpose of the Study:
- To explore the potential of eliminating risk factors for preventing sudden cardiac death.
- To evaluate the current evidence supporting the use of antiarrhythmic agents in managing chronic ventricular ectopy.
Main Methods:
- Review of existing data and clinical observations.
- Analysis of the role of antiarrhythmic agents in patients with left ventricular dysfunction.
Main Results:
- Data suggest that risk factor modification can lead to the prevention of sudden cardiac death.
- The use of antiarrhythmic agents in chronic ventricular ectopy, particularly in patients with left ventricular dysfunction, appears warranted.
Conclusions:
- While large-scale clinical trials are pending, current evidence supports proactive management of ventricular ectopy.
- Future development of novel antiarrhythmic agents holds promise for improved prevention of sudden cardiac death.